Skip to search boxSkip to navigationSkip to main content

Are quinolone-resistant uropathogenic Escherichia coli less virulent?

  • Jordi Vila
    ,
  • Karine Simon
    ,
  • ,
  • Juan P. Horcajada
    ,
  • Maria Velasco
    ,
  • Margarita Barranco
  • Servei de Microbiologia
    ,
  • ,
  • Hospital Clínic – Universitat de Barcelona
Research Output:
Contribution to journal
Article
Peer-review

Publication Information

Output type

Research Output:
Contribution to journal
Article
Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 1039-1042 (4 pages)

Journal (Volume, Issue Number)

Journal of Infectious Diseases (Volume 186, Issue 7)

Publication milestones

  • Published - 01/10/2002

Publication status

Published - 01/10/2002

ISSN

0022-1899

Publication IDs

  • Scopus: 0036788711
  • PubMed: 12232848

Abstract

The prevalence of hemolysin, type 1 fimbriae, P fimbriae, cytotoxic necrotizing factor-1 (CNF-1), aerobactin, and autotransporter toxin (sat) was analyzed by polymerase chain reaction and phenotypic assays of 42 epidemiologically unrelated Escherichia coli strains causing acute pyelonephritis in women (21 nalidixic acid-susceptible and 21 nalidixic acid-resistant strains) and 58 E. coli strains causing cystitis in women (29 nalidixic acid-susceptible and 29 nalidixic acid-resistant strains). Hemolysin and CNF-1 were less prevalent (P < .05) in nalidixic acid-resistant than in nalidixic acid-susceptible E. coli strains from patients with either pyelonephritis (14.3% vs. 52.4%) or cystitis (0% vs. 31.0%). Among E. coli strains causing cystitis, type 1 fimbriae expression was less prevalent (P < .05) in the nalidixic acid-resistant group (55.2%) than in the nalidixic acid-susceptible group (86.2%). None of the nalidixic acid-resistant and 20.7% of the nalidixic acid-susceptible strains causing cystitis showed the proteolytic toxin Sat (P < .05). These results suggest that resistance to quinolones may be associated with a decrease in the presence or the expression of some virulence factors in uropathogenic E. coli.

Funding Details

Presented in part: 11th European Congress of Clinical Microbiology and Infectious Diseases, Istanbul, Turkey, 1–4 April 2001 (abstract P-1022), and in the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, Illinois, 16–20 December 2001 (abstract L-1054). Financial support: Health Spanish Ministry (grant FIS 00/0997).
FundersFunding numbers
Health Spanish Ministry
FIS 00/0997

Publication metrics

Metrics

Scopus
Citations

PlumX, opens in new tab

Captures
59
Citations
158
Mentions
1

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well